Viewing Study NCT00000920


Ignite Creation Date: 2025-12-25 @ 4:26 AM
Ignite Modification Date: 2026-03-28 @ 10:16 PM
Study NCT ID: NCT00000920
Status: COMPLETED
Last Update Posted: 2021-10-29
First Post: 1999-11-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Fortovase (Saquinavir) Given With Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their Newborns
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module